is proud to announce that its cutting-edge generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This recognition ...
PathChat 2a (research use only) is capable of slide level triage, co-pilot assistive discussions ... PathChat integrates advanced generative AI and multimodal analysis which are designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback